IN2014MU00667A - - Google Patents

Info

Publication number
IN2014MU00667A
IN2014MU00667A IN667MU2014A IN2014MU00667A IN 2014MU00667 A IN2014MU00667 A IN 2014MU00667A IN 667MU2014 A IN667MU2014 A IN 667MU2014A IN 2014MU00667 A IN2014MU00667 A IN 2014MU00667A
Authority
IN
India
Prior art keywords
relates
transdermal gel
testosterone
administering
pharmaceutically acceptable
Prior art date
Application number
Inventor
Sehgal Ashish
Bhaskar Pallerla
Patel Aditya
Dadhaniya Dhaval
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Priority to IN667MU2014 priority Critical patent/IN2014MU00667A/en
Priority to US15/121,269 priority patent/US20160361321A1/en
Priority to PCT/IN2015/000101 priority patent/WO2015128876A2/en
Publication of IN2014MU00667A publication Critical patent/IN2014MU00667A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a stable transdermal gel composition comprising Testosterone, a penetration enhancer, a gelling agent with pharmaceutically acceptable excipients. Further, the invention relates to the method of administering the said transdermal gel and its uses thereof.
IN667MU2014 2014-02-25 2015-02-23 IN2014MU00667A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN667MU2014 IN2014MU00667A (en) 2014-02-25 2015-02-23
US15/121,269 US20160361321A1 (en) 2014-02-25 2015-02-23 Stable transdermal testosterone gel
PCT/IN2015/000101 WO2015128876A2 (en) 2014-02-25 2015-02-23 Stable transdermal testosterone gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN667MU2014 IN2014MU00667A (en) 2014-02-25 2015-02-23

Publications (1)

Publication Number Publication Date
IN2014MU00667A true IN2014MU00667A (en) 2015-10-23

Family

ID=54009732

Family Applications (1)

Application Number Title Priority Date Filing Date
IN667MU2014 IN2014MU00667A (en) 2014-02-25 2015-02-23

Country Status (3)

Country Link
US (1) US20160361321A1 (en)
IN (1) IN2014MU00667A (en)
WO (1) WO2015128876A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
EP1634583A1 (en) * 2004-09-09 2006-03-15 Laboratoires Besins International Testosterone gels comprising propylene glycol as penetration enhancer
TR201815853T4 (en) * 2005-10-12 2018-11-21 Besins Healthcare Sarl Testosterone gel for use in the treatment of hypogonadism.

Also Published As

Publication number Publication date
WO2015128876A2 (en) 2015-09-03
US20160361321A1 (en) 2016-12-15
WO2015128876A3 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
MX2023000320A (en) Methods of modulating drug plasma levels using erythrohydroxybupropion.
CA2956871C (en) Compounds active towards bromodomains
IL287604A (en) Formulations of pthrp analogues, transdermal patches thereof, and uses thereof
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
EP3206706A4 (en) Stable injectable composition of pharmaceutically active agents and process for its preparation
MX2023006706A (en) Transdermal delivery of large agents.
PH12017500239A1 (en) Abiraterone acetate formulation and methods of use
IN2014MU00303A (en)
MX2017011521A (en) Topical compositions comprising a corticosteroid.
IN2013MU00711A (en)
WO2015023649A3 (en) Peptides for enhancing transdermal delivery
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX2017012596A (en) A pharmaceutical composition and the use thereof.
EP3265060A4 (en) Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent
UA118474C2 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
MX2016005545A (en) Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same.
MX2018005350A (en) Eflornithine and sulindac, fixed dose combination formulation.
MX2021003908A (en) Long-acting polypeptides and methods of producing and administering same.
EP3100744A4 (en) Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation
PH12017501979A1 (en) Pharmaceutical compound
IN2014MU00667A (en)
EP3100743A4 (en) Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation
NZ725354A (en) Transdermal formulations of pergolide and uses thereof
MX2017001512A (en) Compounds active towards bromodomains.